XML 27 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue:    
Premiums and policy fees $ 7,567,703 $ 7,918,235
Ceded reinsurance premiums and policy fees (2,280,397) (2,553,010)
Net investment income 16,093,592 14,053,528
Other income 236,846 280,303
Revenue before net investment gains (losses) 21,617,744 19,699,056
Net investment gains (losses):    
Other-than-temporary impairments (900,149) 0
Other realized investment gains, net 7,356,275 9,463,843
Change in fair value of equity securities 56,839,751 (2,856,543)
Total net investment gains 63,295,877 6,607,300
Total revenues 84,913,621 26,306,356
Benefits, claims and settlement expenses:    
Life 13,740,517 16,089,474
Ceded reinsurance benefits and claims (2,323,619) (2,882,312)
Annuity 1,021,454 1,029,885
Dividends to policyholders 287,779 302,685
Commissions (109,946) (102,971)
Amortization of cost of insurance acquired 635,815 661,257
Operating expenses 9,429,857 8,368,135
Interest expense 11,600 28,389
Total benefits and other expenses 22,693,457 23,494,542
Income before income taxes 62,220,164 2,811,814
Income tax expense 12,818,983 41,807
Net income 49,401,181 2,770,007
Net income attributable to noncontrolling interest (99,666) (113,397)
Net income attributable to common shareholders $ 49,301,515 $ 2,656,610
Amounts attributable to common shareholders:    
Basic income per share (in dollars per share) $ 15.57 $ 0.84
Diluted income per share (in dollars per share) $ 15.57 $ 0.84
Basic weighted average shares outstanding (in shares) 3,165,541 3,176,757
Diluted weighted average shares outstanding (in shares) 3,165,541 3,176,757